• 1
    Grassi W, Meenagh G, Pascual E, Filippucci E. “Crystal clear”: sonographic assessment of gout and calcium pyrophosphate deposition disease. Semin Arthritis Rheum 2006; 36: 197202.
  • 2
    Dalbeth N, McQueen FM. Use of imaging to evaluate gout and other crystal deposition disorders. Curr Opin Rheumatol 2009; 21: 12431.
  • 3
    Thiele RG, Schlesinger N. Ultrasonography shows active inflammation in clinically unaffected joints in chronic tophaceous gout [abstract]. Arthritis Rheum 2009; 60 Suppl: S565.
  • 4
    Schueller-Weidekamm C, Schueller G, Aringer M. Impact of sonography in gouty arthritis: comparison with conventional radiography, clinical examination, and laboratory findings. Eur J Radiol 2007; 62: 43743.
  • 5
    Perez-Ruiz F, Martin I, Canteli B. Ultrasonographic measurement of tophi as an outcome measure for chronic gout. J Rheumatol 2007; 34: 188893.
  • 6
    Carter JD, Kedar RP, Anderson SR, Osorio AH, Albritton NL, Gnanashanmugam S, et al. An analysis of MRI and ultrasound imaging in patients with gout who have normal plain radiographs. Rheumatology (Oxford) 2009; 48: 14426.
  • 7
    Filippucci E, Scire CA, Delle Sedie A, Iagnocco A, Riente L, Meenagh G, et al. Ultrasound imaging for the rheumatologist XXV: sonographic assessment of the knee on patients with gout and calcium pyrophosphate deposition disease. Clin Exp Rheumatol 2010; 28: 25.
  • 8
    Thiele RG, Schlesinger N. Ultrasonography shows disappearance of monosodium urate crystal deposition on hyaline cartilage after sustained normouricemia is achieved. Rheumatol Int 2010; 30: 495503.
  • 9
    Puig JG, de Miguel E, Castillo MC, Rocha AL, Martinez MA, Torres RJ. Asymptomatic hyperuricemia: impact of ultrasonography. Nucleosides Nucleotides Nucleic Acids 2008; 27: 5925.
  • 10
    Pineda C, Amezcua-Guerra LM, Solano C, Rodriguez-Henriquez P, Hernandez-Diaz C, Vargas A, et al. Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study. Arthritis Res Ther 2011; 13: R4.
  • 11
    Chen LX, Schumacher HR. Gout: can we create an evidence-based systematic approach to diagnosis and management? Best Pract Res Clin Rheumatol 2006; 20: 67384.
  • 12
    Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DL, Yu T. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895900.
  • 13
    Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA, et al. Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 2001; 60: 6419.
  • 14
    Schlesinger N, Thiele RG. The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis 2010; 69: 190712.
  • 15
    Fleiss JL, Levin B, Paik MC. The measurement of interrater agreement. In: Statistical methods for rates and proportions. 3rd ed. New York: John Wiley; 2003. p. 598605.
  • 16
    Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 15974.
  • 17
    Choi H. Epidemiology of crystal arthropathy. Rheum Dis Clin North Am 2006; 32: 25573.
  • 18
    Filippucci E, Riveros MG, Georgescu D, Salaffi F, Grassi W. Hyaline cartilage involvement in patients with gout and calcium pyrophosphate deposition disease: an ultrasound study. Osteoarthritis Cartilage 2009; 17: 17881.
  • 19
    Wright SA, Filippucci E, McVeigh C, Grey A, McCarron M, Grassi W, et al. High-resolution ultrasonography of the first metatarsal phalangeal joint in gout: a controlled study. Ann Rheum Dis 2007; 66: 85964.
  • 20
    Thiele RG, Schlesinger N. Diagnosis of gout by ultrasound. Rheumatology (Oxford). 2007; 46: 111621.
  • 21
    Nalbant S, Corominas H, Hsu B, Chen LX, Schumacher HR, Kitumnuaypong T. Ultrasonography for assessment of subcutaneous nodules. J Rheumatol 2003; 30: 11915.
  • 22
    Zhang W, Doherty M. EULAR evidence based recommendations for gout part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 130111.